176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
17.62%
Net income growth above 1.5x AVGO's 8.21%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
0.44%
Less D&A growth vs. AVGO's 5.26%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
-150.06%
Negative yoy deferred tax while AVGO stands at 300.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-7.56%
Negative yoy SBC while AVGO is 15.38%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
106.64%
Slight usage while AVGO is negative at -420.83%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
176.86%
AR growth while AVGO is negative at -264.71%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
26.97%
Inventory shrinking or stable vs. AVGO's 108.00%, indicating lean supply management. David Dodd would confirm no demand shortfall.
128.31%
A yoy AP increase while AVGO is negative at -228.57%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
-31.20%
Negative yoy usage while AVGO is 166.67%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-758.45%
Both negative yoy, with AVGO at -102.24%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
197.99%
Some CFO growth while AVGO is negative at -39.34%. John Neff would note a short-term liquidity lead over the competitor.
-67.37%
Both yoy lines negative, with AVGO at -16.07%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
100.00%
Acquisition growth of 100.00% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
-115.88%
Negative yoy purchasing while AVGO stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-5.65%
We reduce yoy sales while AVGO is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
100.00%
Growth of 100.00% while AVGO is zero at 0.00%. Bruce Berkowitz sees a moderate difference requiring justification by ROI in these smaller invests.
-5.83%
Both yoy lines negative, with AVGO at -19.64%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-20.58%
We cut debt repayment yoy while AVGO is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
30.90%
We slightly raise equity while AVGO is negative at -64.71%. John Neff sees competitor possibly preserving share count or buying back shares.
No Data
No Data available this quarter, please select a different quarter.